-The Economic Times The country's main planning body on Thursday said it will take a re-look at the just-released poverty figures, which have drawn widespread criticism for its criteria and even elicited concern from the prime minister. The Planning Commission said it will set up a new technical group in the next three months to re-visit the Suresh Tendulkar methodology of estimating poverty and devise a new measure of poverty that will...

-The Times of India After being dormant for nearly a year, the H1N1 virus has made an appearance in Mumbai. A six-year-boy from Mulund tested positive for the virus that claimed several lives during and after the 2009 pandemic, and still continues to haunt neighbouring Pune. The virus had remained 'underground' for the better part of 2011, but suddenly struck Pune in March this year killing five and affecting 95 people in...

-The Times of India Manipur is worst affected by militancy in the country, overtaking J&K and other northeastern states. Mizoram and Tripura are among the most peaceful states. Replying to a question in the Lok Sabha on Tuesday, minister of state for home Jitendra Singh said 246 militancy-related incidents occurred in Manipur in the first three months of 2012. During that period, 34 such incidents occurred in J&K. This year, 21 militants,...

-The Telegraph The controversial poverty data from the Planning Commission has a message for Mamata Banerjee: the Marxists have brought down the number of destitute in Bengal but much more needs to be done. Latest data suggest that the number of poor has dipped by 7.5 percentage points in Bengal between 2004-05 and 2009-10, which covers the last five years of Left rule in the state. Poverty in urban areas in Bengal came...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...